Oral enoximone therapy in chronic heart failure: A placebo-controlled randomized trial

This publication has 25 references indexed in Scilit:

• Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy
  The American Journal of Cardiology, 1986
• Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure
  The American Journal of Cardiology, 1986
• Survival of patients with severe congestive heart failure treated with oral milrinone
  Journal of the American College of Cardiology, 1986
• Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure
  Journal of the American College of Cardiology, 1985
• Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure
  American Heart Journal, 1985
• Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure
  American Heart Journal, 1984
• Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure
  American Heart Journal, 1984
• Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure
  Journal of the American College of Cardiology, 1984
• Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance
  The American Journal of Cardiology, 1984
• Hemodynamic Assessment of Amrinone
  New England Journal of Medicine, 1978